Advances in the application of the glymphatic system for amyloid-beta clearanc

Jiayi LI, Zhongyue LYU, Hao WU, Xiao CHEN, Fan FU, Kaixia YANG, Guomin XIE

Chinese Journal of Alzheimer's Disease and Related Disorders ›› 2025, Vol. 8 ›› Issue (3) : 188-193.

PDF(884 KB)
Home Journals Chinese Journal of Alzheimer's Disease and Related Disorders
Chinese Journal of Alzheimer's Disease and Related Disorders

Abbreviation (ISO4): Chinese Journal of Alzheimer's Disease and Related Disorders      Editor in chief: Jun WANG

About  /  Aim & scope  /  Editorial board  /  Indexed  /  Contact  / 
PDF(884 KB)
Chinese Journal of Alzheimer's Disease and Related Disorders ›› 2025, Vol. 8 ›› Issue (3) : 188-193. DOI: 10.3969/j.issn.2096-5516.2025.03.006
Review

Advances in the application of the glymphatic system for amyloid-beta clearanc

Author information +
History +

Abstract

Alzheimer's disease (AD) is the most common neurodegenerative disease worldwide and a leading cause of dementia. Currently, there are no highly effective treatments for this condition. The imbalance between the production and clearance of Aβ(amyloid-beta) protein is considered a primary pathogenic mechanism of AD. Enhancing the clearance of Aβ in the brain during the early stages can delay the onset and progression of AD. In recent years, with the introduction of the concept of the glymphatic system and the discovery of meningeal lymphatic vessels, the directional transport of fluids within the central nervous system has become a research hotspot. The glymphatic system plays a crucial role in clearing amyloid-beta protein and holds promise as a novel approach to combat neurodegenerative diseases. This review aims to summarize the current research progress on the role of the brain's glymphatic system in AD treatment and explore its potential applications in disease management.

Key words

Alzheimer's disease / Amyloid-beta / Glymphatic system / Neurodegenerative diseases / Aging

Cite this article

Download Citations
Jiayi LI , Zhongyue LYU , Hao WU , et al . Advances in the application of the glymphatic system for amyloid-beta clearanc[J]. Chinese Journal of Alzheimer's Disease and Related Disorders. 2025, 8(3): 188-193 https://doi.org/10.3969/j.issn.2096-5516.2025.03.006

References

[1]
KnopmaN DS, Amieva H, Petersen RC, et al. Alzheimer disease[J]. Nat Rev Dis Primers, 2021, 7(1): 33.
[2]
Chen GF, Xu TH, Yan Y, et al. Amyloid beta: structure, biology and structure-based therapeutic development[J]. Acta Pharmacol Sin, 2017, 38(9): 1205-1235.
[3]
Cheng Y, Tian DY, Wang YJ, et al. Peripheral clearance of brain-derived Aβ in Alzheimer’s disease: pathophysiology and therapeutic perspectives[J]. Transl Neurodegener, 2020, 9: 16.
[4]
Hughes C, Choi ML, Yi JH, et al. Beta amyloid aggregates induce sensitised TLR4 signalling causing long-term potentiation deficit and rat neuronal cell death[J]. Commun Biol, 2020, 3(1): 79.
[5]
Ligocki AP, Vinson AV, Yachnis AT, et al. Cerebrospinal fluid flow extends to peripheral nerves further unifying the nervous system[J]. Sci Adv, 2024, 10(36): eadn3259.
[6]
Iliff JJ, Wang M, Zeppenfeld DM, et al. Cerebral arterial pulsation drives paravascular CSF-interstitial fluid exchange in the murine brain[J]. J Neurosci, 2013, 33(46): 18190-18199.
[7]
Rasmussen MK, Mestre H, Nedergaard M, et al. Fluid transport in the brain[J]. Physiol Rev, 2022, 102(2): 1025-1151.
[8]
Shetty AK, Zanirati G. The interstitial system of the brain in health and disease[J]. Aging Dis, 2020, 11(1): 200-211.
[9]
Ahn JH, Cho H, Kim JH, et al. Meningeal lymphatic vessels at the skull base drain cerebrospinal fluid[J]. Nature, 2019, 572(7767): 62-66.
[10]
Louveau A, Smirnov I, Keyes TJ, et al. Structural and functional features of central nervous system lymphatic vessels[J]. Nature, 2015, 523(7560): 337-341.
[11]
Da Mesquita S, Papadopoulos Z, Dykstra T, et al. Meningeal lymphatics affect microglia responses and anti-Aβ immunotherapy[J]. Nature, 2021, 593(7858): 255-260.
[12]
Absinta M, Ha SK, Nair G, et al. Human and nonhuman primate meninges harbor lymphatic vessels that can be visualized noninvasively by MRI[J]. eLife, 2017, 6: e29738.
[13]
Kang JE, Lim MM, Bateman RJ, et al. Amyloid-β dynamics are regulated by orexin and the sleep-wake cycle[J]. Science, 2009, 326(5955): 1005.
[14]
Kress BT, Iliff JJ, Xia M, et al. Impairment of paravascular clearance pathways in the aging brain[J]. Ann Neurol, 2014, 76(6): 845.
[15]
Vasciaveo V, Iadarola A, Casile A, et al. Sleep fragmentation affects glymphatic system through the different expression of AQP4 in wild type and 5xFAD mouse models[J]. Acta Neuropathol Commun, 2023, 11(1): 16.
[16]
Mestre H, Tithof J, Du T, et al. Flow of cerebrospinal fluid is driven by arterial pulsations and is reduced in hypertension[J]. Nat Commun, 2018, 9: 4878.
[17]
Kiviniemi V, Wang X, Korhonen V, et al. Ultra-fast magnetic resonance encephalography of physiological brain activity - Glymphatic pulsation mechanisms?[J]. J Cereb Blood Flow Metab, 2015, 36(6): 1033.
[18]
Li L, Ding G, Zhang L, et al. Aging-related alterations of glymphatic transport in rat: in vivo magnetic resonance imaging and kinetic study[J]. Front Aging Neurosci, 2022, 14.
[19]
Murdock MH, Yang CY, Sun N, et al. Multisensory gamma stimulation promotes glymphatic clearance of amyloid[J]. Nature, 2024, 627(8002): 149-156.
[20]
Semyachkina-Glushkovskaya O, Penzel T, Blokhina I, et al. Night photostimulation of clearance of beta-amyloid from mouse brain: new strategies in preventing Alzheimer's disease[J]. Cells, 2021, 10(12): 3289.
[21]
Liu X, Naomi SSM, Sharon WL, et al. The applications of focused ultrasound (FUS) in Alzheimer's disease treatment: a systematic review on both animal and human studies[J]. Aging Dis, 2021, 12(8): 1977-2002.
[22]
Salehpour F, Khademi M, Bragin DE, et al. Photobiomodulation therapy and the glymphatic system: promising applications for augmenting the brain lymphatic drainage system[J]. Int J Mol Sci, 2022, 23(6): 2975.
[23]
Feng S, Wu C, Zou P, et al. High-intensity interval training ameliorates Alzheimer's disease-like pathology by regulating astrocyte phenotype-associated AQP4 polarization[J]. Theranostics, 2023, 13(10): 3434-3450.
[24]
Murdock MH, Yang CY, Sun N, et al. Multisensory gamma stimulation promotes glymphatic clearance of amyloid[J]. Nature, 2024, 627(8002): 149-156.
[25]
Gaggi NL, Iosifescu DV. Transcranial photobiomodulation: an emerging therapeutic method to enhance brain bioenergetics[J]. Neuropsychopharmacology, 2024, 50(1): 314-315.
[26]
Lee Y, Choi Y, Park EJ, et al. Improvement of glymphatic-lymphatic drainage of beta-amyloid by focused ultrasound in Alzheimer’s disease model[J]. Sci Rep, 2020, 10: 16144.
[27]
Ye D, Chen S, Liu Y, et al. Mechanically manipulating glymphatic transport by ultrasound combined with microbubbles[J]. Proc National Acad Sci U S A, 2023, 120(21): e2212933120.
[28]
Lin Y, Jin J, Lv R, et al. Repetitive transcranial magnetic stimulation increases the brain’s drainage efficiency in a mouse model of Alzheimer’s disease[J]. Acta Neuropathologica Communications, 2021, 9(1): 102.
[29]
Li MN, Jing YH, Wu C, et al. Continuous theta burst stimulation dilates meningeal lymphatic vessels by up-regulating VEGF-C in meninges[J]. Neurosci Lett, 2020, 735: 135197.
[30]
Chen X, Dong GY, Wang LX, et al. High‐frequency transcranial magnetic stimulation protects APP/PS1 mice against Alzheimer's disease progress by reducing APOE and enhancing autophagy[J]. Brain Behav, 2020, 10(8): e01740.
[31]
Sun X, Dias L, Peng C, et al. 40 Hz light flickering facilitates the glymphatic flow via adenosine signaling in mice[J]. Cell Discovery, 2024, 10(1): 1-17.
[32]
Bozzelli PL, Tsai LH. Treating insomnia with 40 Hz light flicker[J]. Cell Research, 2024, 34(5): 333-334.
[33]
He XF, Liu DX, Zhang Q, et al. Voluntary exercise promotes glymphatic clearance of amyloid beta and reduces the activation of astrocytes and microglia in aged mice[J]. Front Mol Neurosci, 2017, 10: 144.
[34]
Eide PK, Ringstad G. MRI with intrathecal MRI gadolinium contrast medium administration: a possible method to assess glymphatic function in human brain[J]. Acta Radiologica Open, 2015, 4(11): 205846011560963.
[35]
陈泽然, 黄梦颖, 曾利川, 等. 应用于人脑胶质淋巴系统的磁共振成像技术研究进展[J]. 中国全科医学, 2024, 27(26): 3314-3319.
[36]
Ding XB, Wang XX, Xia DH, et al. Impaired meningeal lymphatic drainage in patients with idiopathic parkinson's disease[J]. Nat Med, 2021, 27(3): 411-418.
[37]
Taoka T, Masutani Y, Kawai H, et al. Evaluation of glymphatic system activity with the diffusion MR technique: diffusion tensor image analysis along the perivascular space (DTI-ALPS) in Alzheimer's disease cases[J]. Japan J Radiol, 2017, 35(4): 172-178.
[38]
Hsu J, Wei Y, Toh CH, et al. Magnetic resonance images implicate that glymphatic alterations mediate cognitive dysfunction in Alzheimer disease[J]. Ann Neurol, 2023, 93(1): 164-174.
[39]
杜晓岚, 段曦瑞, 李国臣, 等. 磁共振成像技术在人脑胶质淋巴系统研究的现状与挑战[J]. 磁共振成像, 2024, 15(11): 180-184.
[40]
Zhang W, Xiao D, Mao Q, et al. Role of neuroinflammation in neurodegeneration development[J]. Signal Transduct Target Ther, 2023, 8(1):267.
[41]
Chong PLH, Garic D, Shen MD, et al. Sleep, cerebrospinal fluid, and the glymphatic system: A systematic review[J]. Sleep Medicine Reviews, 2022, 61: 101572.
[42]
Mestre H, Tithof J, DU T, et al. Flow of cerebrospinal fluid is driven by arterial pulsations and is reduced in hypertension[J]. Nat Commun, 2018, 9: 4878.
[43]
Formolo DA, Yu J, Lin K, et al. Leveraging the glymphatic and meningeal lymphatic systems as therapeutic strategies in Alzheimer's disease: an updated overview of nonpharmacological therapies[J]. Mol Neurodegener, 2023, 18: 26.
[44]
Wang Y, Li X, Jia D, et al. Exploring polypharmacy burden among elderly patients with chronic diseases in chinese community: a cross-sectional study[J]. BMC Geriatr, 2021, 21: 308.
[45]
Kass DA, Hare JM, Georgakopoulos D, et al. Murine cardiac function: a cautionary tail[J]. Cir Res, 1998, 82(4): 519-522.
PDF(884 KB)

Accesses

Citation

Detail

Sections
Recommended

/